347 related articles for article (PubMed ID: 30733512)
1. Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study.
Busch C; Wakabayashi T; Sato T; Fukushima Y; Hara C; Shiraki N; Winegarner A; Nishida K; Sakaguchi H; Nishida K
Sci Rep; 2019 Feb; 9(1):1561. PubMed ID: 30733512
[TBL] [Abstract][Full Text] [Related]
2. RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
Winegarner A; Wakabayashi T; Hara-Ueno C; Sato T; Busch C; Fukushima Y; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
Retina; 2018 Oct; 38(10):2067-2072. PubMed ID: 28902097
[TBL] [Abstract][Full Text] [Related]
3. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
4. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
[TBL] [Abstract][Full Text] [Related]
5. OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept.
Dastiridou A; Karathanou K; Riga P; Anagnostopoulou S; Balasubramanian S; Mataftsi A; Brazitikos P; Ziakas N; Androudi S
Ocul Immunol Inflamm; 2021 Jul; 29(5):926-931. PubMed ID: 31951761
[No Abstract] [Full Text] [Related]
6. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion.
Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography angiography analysis of microvascular abnormalities and vessel density in treatment-naïve eyes with diabetic macular edema.
Braham IZ; Kaouel H; Boukari M; Ammous I; Errais K; Boussen IM; Zhioua R
BMC Ophthalmol; 2022 Nov; 22(1):418. PubMed ID: 36329416
[TBL] [Abstract][Full Text] [Related]
8. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Alagorie AR; Nittala MG; Velaga S; Zhou B; Rusakevich AM; Wykoff CC; Sadda SR
JAMA Ophthalmol; 2020 Aug; 138(8):851-857. PubMed ID: 32584384
[TBL] [Abstract][Full Text] [Related]
9. Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema.
Cheong KX; Lee SY; Ang M; Teo KYC
Turk J Ophthalmol; 2020 Dec; 50(6):343-350. PubMed ID: 33389934
[TBL] [Abstract][Full Text] [Related]
10. Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment.
Moon BG; Um T; Lee J; Yoon YH
Ophthalmol Retina; 2018 Mar; 2(3):235-243. PubMed ID: 31047592
[TBL] [Abstract][Full Text] [Related]
11. Optical Coherence Tomography Angiography in Diabetic Macular Edema Treated with Intravitreal Aflibercept: A 48-Week Observational Study (the DOCTA Study).
Korobelnik JF; Gaucher D; Baillif S; Creuzot-Garcher C; Kodjikian L; Weber M
Ophthalmologica; 2023; 246(2):71-80. PubMed ID: 36646050
[TBL] [Abstract][Full Text] [Related]
12. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
Bahrami B; Hong T; Zhu M; Schlub TE; Chang A
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1133-1140. PubMed ID: 28238195
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.
Figueiredo N; Srivastava SK; Singh RP; Babiuch A; Sharma S; Rachitskaya A; Talcott K; Reese J; Hu M; Ehlers JP
Ophthalmol Retina; 2020 Feb; 4(2):154-163. PubMed ID: 31757691
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal aflibercept for diabetic macular oedema: Moorfields' real-world 12-month visual acuity and anatomical outcomes.
Lukic M; Williams G; Shalchi Z; Sim D; Patel PJ; Keane PA; Hykin PG; Sivaprasad S; Menon D; Bruynseels A; Hamilton RD; Rajendram R
Eur J Ophthalmol; 2020 May; 30(3):557-562. PubMed ID: 30808179
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.
Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK
Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept-A Prospective Study.
Huang YT; Wang I; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Chen CH; Wu WC; Tsai YY
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454378
[TBL] [Abstract][Full Text] [Related]
17. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
[TBL] [Abstract][Full Text] [Related]
18. Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography.
AttaAllah HR; Mohamed AAM; Ali MA
Int Ophthalmol; 2019 Aug; 39(8):1845-1859. PubMed ID: 30194547
[TBL] [Abstract][Full Text] [Related]
19. AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes.
Bahrami B; Hong T; Schlub TE; Chang AA
Retina; 2019 Jan; 39(1):61-68. PubMed ID: 30015767
[TBL] [Abstract][Full Text] [Related]
20. OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study.
Sun Z; Tang F; Wong R; Lok J; Szeto SKH; Chan JCK; Chan CKM; Tham CC; Ng DS; Cheung CY
Ophthalmology; 2019 Dec; 126(12):1675-1684. PubMed ID: 31358386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]